Audit v2.1
2026 MDL 2738 CALIBRATION
Talc Precision Input v4.26
Settlement Audit.
Calibrate your potential recovery based on clinical staging and bankruptcy trial premiums.
$
Forensic Expert Toggles
J&J Bankruptcy Update Feb 2026: Third Chapter 11 filing rejected. Claimants now entitled to full state-court jury paths.
Audit Result
Ovarian Cancer - Stage III-IV / Long-term Use (10-20 Years)
$4,162,500
$2,289,375$6,660,000
Base Valuation$1,500,000
Ec. Damages (x2.5)$375,000
Forensic Net PayoutEstimated after 2026 Admin Liens
$3,121,875S-Class Actuarial Engine v2.1 @ 2026
MDL
MDL
MDL
Regulatory Audit
MDL 2738 Analysts
The Ovarian Cancer Points Matrix
The 2026 Talcum Powder litigation landscape has shifted from global bankruptcy settlements to aggressive state-court trial strategies following the dismissal of J&J's redundant Chapter 11 filings.
Evidence Required
- Pathology: High-Grade Serous
- Talc-Mineral Biopsy Evidence
- Decadal Usage Confirmation
- Pharmacy Purchase Records
2026 Trial Status
Bellwether Phase: Active
Juries are currently assigning punitive weights based on J&J's long-term internal knowledge of asbestos contamination.